These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34284806)

  • 21. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
    Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
    Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased Circulating MANF in Women with PCOS is Elevated by Metformin Therapy and is Inversely Correlated with Insulin Resistance and Hyperandrogenism.
    Wei J; Wang C; Yang G; Jia Y; Li Y; Deng W; Long M; Wang C; Liu D
    Horm Metab Res; 2020 Feb; 52(2):109-116. PubMed ID: 32067218
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated Serum Leptin Levels as a Predictive Marker for Polycystic Ovary Syndrome.
    Peng Y; Yang H; Song J; Feng D; Na Z; Jiang H; Meng Y; Shi B; Li D
    Front Endocrinol (Lausanne); 2022; 13():845165. PubMed ID: 35355566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-atherogenic aspect of metformin treatment in insulin resistant women with the polycystic ovary syndrome: role of the newly established pro-inflammatory adipokine Acute-phase Serum Amyloid A; evidence of an adipose tissue-monocyte axis.
    Tan BK; Adya R; Shan X; Aghilla M; Lehnert H; Keay SD; Randeva HS
    Atherosclerosis; 2011 Jun; 216(2):402-8. PubMed ID: 20869715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of resveratrol and metformin on ovarian reserve and ultrastructure in PCOS: an experimental study.
    Furat Rencber S; Kurnaz Ozbek S; Eraldemır C; Sezer Z; Kum T; Ceylan S; Guzel E
    J Ovarian Res; 2018 Jun; 11(1):55. PubMed ID: 29958542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome.
    Ou HT; Chen PC; Wu MH
    J Formos Med Assoc; 2017 Feb; 116(2):80-89. PubMed ID: 27131512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.
    Nardo LG; Rai R
    Gynecol Endocrinol; 2001 Oct; 15(5):373-80. PubMed ID: 11727360
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice.
    Xue J; Li X; Liu P; Li K; Sha L; Yang X; Zhu L; Wang Z; Dong Y; Zhang L; Lei H; Zhang X; Dong X; Wang H
    Endocr J; 2019 Oct; 66(10):859-870. PubMed ID: 31270279
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome.
    Wu J; Zhu Y; Jiang Y; Cao Y
    Gynecol Endocrinol; 2008 Jul; 24(7):392-8. PubMed ID: 18608522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome.
    Savastano S; Valentino R; Pizza G; De Rosa A; Orio F; Passaretti F; Formisano P; Lombardi G; Beguinot F; Colao A
    J Endocrinol Invest; 2010; 33(7):446-50. PubMed ID: 20671408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated serum levels of anti-Müllerian hormone can be introduced as a new diagnostic marker for polycystic ovary syndrome.
    Sahmay S; Atakul N; Aydogan B; Aydin Y; Imamoglu M; Seyisoglu H
    Acta Obstet Gynecol Scand; 2013 Dec; 92(12):1369-74. PubMed ID: 23980726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparison between rimonabant and metformin in reducing biochemical hyperandrogenaemia and insulin resistance in patients with polycystic ovary syndrome (PCOS): a randomized open-label parallel study.
    Sathyapalan T; Cho LW; Kilpatrick ES; Coady AM; Atkin SL
    Clin Endocrinol (Oxf); 2008 Dec; 69(6):931-5. PubMed ID: 18410553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
    Arslanian SA; Lewy V; Danadian K; Saad R
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study.
    Pau CT; Keefe C; Duran J; Welt CK
    J Clin Endocrinol Metab; 2014 May; 99(5):1870-8. PubMed ID: 24606093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis.
    Wang R; Li W; Bordewijk EM; Legro RS; Zhang H; Wu X; Gao J; Morin-Papunen L; Homburg R; König TE; Moll E; Kar S; Huang W; Johnson NP; Amer SA; Vegetti W; Palomba S; Falbo A; Özmen Ü; Nazik H; Williams CD; Federica G; Lord J; Sahin Y; Bhattacharya S; Norman RJ; van Wely M; Mol BW; ;
    Hum Reprod Update; 2019 Nov; 25(6):717-732. PubMed ID: 31647106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.
    Meenakumari KJ; Agarwal S; Krishna A; Pandey LK
    Braz J Med Biol Res; 2004 Nov; 37(11):1637-44. PubMed ID: 15517078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.